Vanguard Fiduciary Trust
CDIO icon

Vanguard Fiduciary Trust’s Cardio Diagnostics CDIO Stock Holding History

Vanguard Fiduciary Trust’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.18K Sell
2,824
-1,145
-29% -$2.17K ﹤0.01% 4054
2026
Q1 		$7.74K Buy
+3,969
New +$10.4K ﹤0.01% 4017

Other funds holding CDIO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust's CDIO Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Cardio Diagnostics (CDIO) stake by 29% in Q2 2026, selling an estimated $2.17K and leaving 2,824 shares worth $6.18K. The position accounts for ﹤0.01% of the portfolio, ranked #4054.

Vanguard Fiduciary Trust first reported a position in CDIO in Q1 2026 and has held it in 2 quarters since. The position peaked at $7.74K in Q1 2026. 17 funds tracked by Wall St. Rank hold CDIO as of Q2 2026.

  • Vanguard Fiduciary Trust held 2,824 shares of Cardio Diagnostics worth $6.18K as of Q2 2026.
  • Vanguard Fiduciary Trust sold 1,145 Cardio Diagnostics shares in Q2 2026, an estimated $2.17K.
  • Cardio Diagnostics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #4054 holding.
  • Vanguard Fiduciary Trust first reported a position in Cardio Diagnostics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Cardio Diagnostics position peaked at $7.74K in Q1 2026.
  • 17 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.